On 4 October 2018, the BIA submitted an application for permission to intervene in the UK Supreme Court's review of Actavis Group PTC EHF vs ICOS Corporation. This document is the Statement of Grounds for the application.
The ABPI and BIA have worked together to develop this joint submission to the MHRA consultation. We have provided our members’ views on how the MHRA’s legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s exit, with no Implementation Period. This consultation covers no-deal proposals on medicines, clinical trials and medical devices.
19 Oct 18
Finance Tax Investment, Skills People And Talent, Guidance document